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Abstract
Background: Guidelines on smoking cessation (SC) emphasize healthcare cooperation and community
pharmacists’ involvement. This study explored the familiarity and implementation of the National SC Guideline in
Finnish community pharmacies, factors relating to Guideline familiarity, implementation and provision of SC
services.
Methods: A nationwide mail survey was sent to a systematic, sample of community pharmacy owners and staff
pharmacists (total n = 2291). Response rate was 54% (n = 1190). Factors related to the SC Guideline familiarity
were assessed by bivariate and multivariate analysis.
Results: Almost half (47%) of the respondents (n = 1190) were familiar with the SC Guideline and familiarity
enhanced Guideline implementation. The familiarity was associated with the respondents’ perceptions of their
personal SC skills and knowledge (OR 3.8); of customers’ value of counseling on nicotine replacement therapy
(NRT) (OR 3.3); and regular use of a pocket card supporting SC counseling (OR 3.0). Pharmacists’ workplaces’
characteristics, such as size and geographical location were not associated with familiarity. In addition to
recommending NRT, the pharmacists familiar with the Guideline used more frequently other Guideline-based
SC methods, such as recommended non-pharmacological SC aids, compared to unfamiliar respondents.
Conclusions: SC Guideline familiarity and implementation is crucial for community pharmacists’ involvement in
SC actions in addition to selling NRT products. Pharmacists can constitute a potential public health resource in
SC easily accessible throughout the country.
Background
Smoking cessation (SC) is one of the most effective ways
to promote public health and reduce healthcare costs
[1-5]. Health care professionals play a key role in SC
[1,4,5]. To support SC, evidence-based guidelines have
been established [4-7]. Despite this, SC does not routi-
nely take place in healthcare in the recommended way
[4,6-10]. Recent British and US guidelines on SC
emphasize cooperation in healthcare and community
pharmacists’ involvement [4,5]. Correspondingly, the
Finnish Current Care Guideline (later SC Guideline)
published in 2002 and updated in 2006 has been
developed from the multidisciplinary viewpoint by the
Finnish Medical Society [7]. According to it, all health-
care professionals have specified SC responsibilities, and
the local cooperation between them should facilitate SC
by increasing and strengthening contacts with patients
[11,12].
Some studies of the implementation process of the SC
guidelines have been made [4,6,10,13]. These studies
and the literature on guideline implementation provide
strong evidence that changing healthcare professionals’
practices requires more effort than solely disseminating
the guidelines; systematic efforts are needed to promote
their usage [4,13-15]. Most of these studies are focused
on physicians and their practices, and few studies have
explored the implementation of guidelines among other
healthcare professionals [6,10,14,16-19]. Community
pharmacists’ role in SC has been widely studied and
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according to the systematic reviews conducted, their
participation in SC may increase cessation rates [20-22].
Still, community pharmacists could extent their partici-
pation in SC by several alternative actions (Additional
file 1, Table S1) [8,23-27]. To our knowledge this is the
first study exploring the implementation of a National
SC guideline among them.
The Finnish healthcare system is largely based on the
public healthcare system, which is complemented by
private sector services [28]. The National public health
policy has had a strong emphasis on preventive services
[28,29]. SC has been one of the priorities in preventive
healthcare, with the focus on strong socioeconomic gra-
dient in smoking prevalence [30]. Local SC services are
coordinated by the healthcare centers [28,29].
Finnish community pharmacies are privately owned by
pharmacists and highly regulated to emphasize public
health goals in their operations [31]. Finnish community
pharmacists have proactively developed professional ser-
vices, particularly patient counseling on prescription and
non-prescription medications [32]. A long-term strategic
goal of the Association of Finnish Pharmacies (AFP; the
association of pharmacy owners) has been to establish a
network of specialized community pharmacists on major
public health concerns coordinating local services for
customers having asthma, diabetes or cardiovascular dis-
eases [33]. These initiatives have been supported by
authorities and there is evidence that they have been
successful [32]. The Finnish medicine users value the
Finnish pharmacy system and pharmacists are appre-
ciated among the three most commonly used and reli-
able sources of medicines information in addition to
physicians and patient information leaflets [34,35].
Finnish community pharmacists are strongly encour-
aged to be involved in SC by the SC Guideline [7]. The
professional organizations, particularly the Association
of Finnish Pharmacies, have actively supported commu-
nity pharmacists’ involvement in SC and the implemen-
tation of the SC Guideline, e.g., by national training
campaigns and SC counseling aid materials [36].
The SC Guideline was developed by a multidisciplin-
ary expert group and it is based on robust scientific evi-
dence [7]. It provides background information on
tobacco and smoking as a health risk. Furthermore, the
Guideline introduces a wide range of interventions
found effective in SC, which are applicable in various
health care settings. It’s recommendations are targeted
to all health care professionals including community
pharmacists (Additional File 2, Table S2). The Guideline
is distributed nationwide by free internet access along
with online education supporting its implementation.
The objective of this study was to explore the imple-
mentation of the National SC Guideline in Finnish com-
munity pharmacies, factors related to familiarity with it
and its implementation, and actions taken to provide SC
services.
Methods
Study design
The survey questionnaire was mailed to a systematic
national sample of every second Finnish community
pharmacist (n = 2291), including pharmacy owners (n =
292) and staff pharmacists (n = 2235) in November
2006. The sample was systematically drawn from mem-
ber registers of the three national pharmacists’ profes-
sional associations. At the time of the survey, their
registers covered 100% of the Finnish pharmacy owners
and 93% of the staff pharmacists with B.Sc. (Pharm.)
and M.Sc. (Pharm.) degree. Finnish pharmacy owners
belong to the Association of Finnish Pharmacies (AFP).
Staff pharmacists with a B.Sc (Pharm.) belong to the
Finnish Pharmacists’ Association and staff pharmacists
with a M.Sc. (Pharm.) degree belong to either the Fin-
nish Pharmacists’ Association (FPA) (with 369 M.Sc.
members at the time of the survey) or the Finnish Phar-
macists’ Society (FPS) (with 379 members). Thus, the
survey was sent to 185 M.Sc. members of FPA and to
190 M.Sc. members of FPS. For the statistical analysis
all the received responses were combined.
After two reminders and one repeat questionnaire, we
received responses from a total of 1190 community
pharmacists, the final response rate being 54% (Table 1).
The respondents well represented the target population
according to demographic characteristics, but respon-
dents who specialized in the treatment of asthma, dia-
betes or cardiovascular diseases were of a higher
percentage compared to those unspecialized in those
fields (Table 1).
The study was conducted following scientific ethics
[37]. To secure respondents anonymity, all the responses
were handled in numeric form. No ethics committee’s
approval was required for this kind of study under the
ethical guidelines of the University of Helsinki.
Survey instrument
The survey instrument was based on the literature on
guideline dissemination and implementation
[6,13-16,38,39]. As the familiarity with a guideline is the
first step in implementation [15], one of the key ques-
tions in our survey was designed to assess just this. The
structured question was adopted from earlier studies
conducted among physicians and public health nurses
(Sandström P et al. 2009, unpublished) and was modi-
fied for pharmacy practice as follows: “How familiar are
you with the SC Guideline?” The following options were
given: “I have read the Guideline through carefully; I am
familiar with its main principles; I have glanced through
it; I have heard about it"; and “I am not familiar with it”.
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For the analysis the options “I have read the Guideline
carefully through” and “I am familiar with its main prin-
ciples” were combined to make up a group of respon-
dents “Familiar with the Guideline.” The remainder of
the respondents was categorized as “Unfamiliar with the
Guideline”.
According to the Finnish SC Guideline, it is the duty
of the pharmacy owners to arrange for sufficient SC
training for their staff pharmacists (Additional file 2,
Table S2) [7]. This was measured by asking respondents
to assess their participation in continuing SC education
(Tables 1, 2 and 3). The SC Guideline was used as a
basis for the measuring of SC actions taken at commu-
nity pharmacies (Table 4). It recommends community
pharmacists to ensure sufficient and rational use of SC
medication and to support non-pharmacological SC [7].
This means that pharmacists are expected to assess indi-
vidual customer’s level of addiction to plan the treat-
ment and its follow-up accordingly. They are also
expected to recommend the use of non-pharmacological
SC aids, such as written materials or internet portals. In
our survey this was measured by a set of questions
assessing the frequency of recommending Guideline-
based pharmacological and non-pharmacological SC
Table 1 Characteristics of the respondents (n = 1190) and the target population (n = 5053)
Variable Respondents
(n = 1190)
Target population
(n = 5053)
p-value**
% n % n
Variables associated with the respondent pharmacist
Professional status 0.858
B.Sc. Pharmacist (Staff pharmacist) 70 833 72 3654
M.Sc. Pharmacist (Staff pharmacist) 18 217 16 815
Pharmacy owner 12 140 12 584
Total 100 1190 100 5053
Specialization of the respondent* <0.001
Asthma 25 272 14 706
Diabetes 21 230 13 680
Cardiovascular diseases 20 221 12 613
Participation in continuing education in SC
In-house training 48 568 na na
Continuing education (CE) 25 302 na na
In-house training by a drug company 40 477 na na
CE by a drug company 33 398 na na
Not participated 20 229 na na
Variables associated with the respondent’s working place
Location by province 0.790
Southern Finland 39 459 41 2087
Western Finland 33 392 35 1773
Eastern Finland 15 174 12 604
Northern Finland 13 157 12 589
Total 100 1182 100 5053
Annual prescription volume 0.161
Less than 40 000 21 252 16 782
40 000-80 000 38 452 34 1751
80 001 or more 41 475 50 2520
Total 100 1179 100 5053
Ownership 0.295
Privately owned 94 1108 91 4589
University owned 6 75 9 464
Total 100 1183 100 5053
* Based on the professional programs run by the AFP since late 1990 s to assure community pharmacies’ contribution to the national public health goals.
Information available on pharmacists working in privately owned community pharmacies (missing data from the two university owned pharmacies covering
about 11% of the total prescription volume).
** Counted between the of respondents and the target population in relation to the background variable
na = not available
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treatment options to the smoking pharmacy customers
(Table 4).
In addition, the SC Guideline [7] expects pharmacists
to be familiar with the Finnish version of the 5A’s Inter-
vention (6K’s in Finnish) [4,40]. Respondents were asked
about the use of the 5A’s Intervention with the options:
“Always; Often; With every second customer; Some-
times; Never.” For the analysis, options “Always” and
“Often” were reclassified as “At least often” (Table 4).
The remaining options were categorized as “Not often”.
Table 2 Proportion (%) of the respondents familiar with
the SC Guideline (n = 525)
Variable % p-
value*
Factors associated with the responding pharmacist
Professional status <0.001
B.Sc. Pharmacist (Staff pharmacist) 41
M.Sc. Pharmacist (Staff pharmacist) 51
Pharmacy owner 59
Age (years) <0.001
29 or less 35
30-39 41
40-49 48
50-59 51
60 or more 57
Graduation date 0.020
In the 2000’s 41
In the 1990’s 42
In the 1980’s 48
In the 1970’s or earlier 53
Specialization in asthma** <0.001
Yes 61
No 40
Specialization in diabetes** 0.082
Yes 40
No 46
Specialization in cardiovascular diseases** 0.093
Yes 50
No 44
Participation in continuing education supporting SC <0.001
Yes 50
No 23
Perceives health care’s support needed in SC <0.001
Always or almost always 51
Rarely 39
Never 20
Perceives own personal skills and knowledge adequate to
support SC
<0.001
Agree 50
No opinion 36
Disagree 17
Perceives customers value of NRT counseling 0.025
Agree 46
No opinion 44
Disagree 27
Perceives cigarette’s smoke extremely detrimental to
health
(Scale: 1 = strongly disagree; 10 = strongly agree)
0.024
Yes 46
No 36
Smoked at least 100 cigarettes up to date 0.003
Yes 52
No 42
Factors associated with the respondent’s workplace
Location by province 0.042
Table 2 Proportion (%) of the respondents familiar with
the SC Guideline (n = 525) (Continued)
Southern Finland 47
Eastern Finland 40
Western Finland 42
Northern Finland 53
Annual prescription volume 0.276
Less than 40 000 42
40 000-80 000 48
80 001 or more 44
Ownership 0.990
Privately owned 45
University owned 45
Dispensing counter design <0.001
Traditional counter 37
Sit-down counseling station 48
Both in use 51
SC services available in the respondent’s workplace
Individually tailored SC service 0.005
Yes 57
No 44
Smoking pass 0.005
Yes, used often 75
Yes, used sometimes 61
No 46
SC counseling supporting pocket card in use <0.001
Yes, used often 64
Yes, used sometimes 48
No 31
In-house guideline in NRT dispensing <0.001
Yes, written guideline available 59
Yes, oral guideline available 56
No 36
Participation in local multidisciplinary SC actions <0.001
Yes 69
No 39
Total (all the respondents) 47
* Difference between the levels of each background variable.
**Based on the professional programs run by the AFP since late 1990 s to
assure community pharmacies’ contribution to the national public health
goals. Information available on pharmacists working in privately owned
community pharmacies (missing data from the two university owned
pharmacies covering about 11% of the total prescription volume).
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Background variables
The background variables used in this study were
selected on the basis of the literature [13,15,16,38,39].
They were related to characteristics of the responding
pharmacist; characteristics of his/her workplace; and SC
actions that have taken place at his/her workplace
(Table 2). This categorization of the background vari-
ables originates from the meta-review of Francke et al.
(2008), in which guideline implementation was identified
to be affected by factors related to guideline content,
patient, healthcare professional and environment [15].
In addition to these variables, participation in local SC
multidisciplinary teamwork was used as a background
variable (Tables 2 and 3) for familiarity with the Guide-
line and measuring its implementation (Table 4).
All background variables for Guideline familiarity and
implementation were used in their original format,
except the one related to pharmacist’s participation in
continuing SC education (Table 1). It was reclassified as
a dichotomic variable (yes/no) for the statistical analysis
Table 3 Variables associated with the familiarity of SC Guideline in the multivariate analysis (logistic regression
analysis)
Variable Unadjusted Adjusted*
OR (95% Cl) p-value OR (95% CI) p-value
Factors associated with the responding pharmacist
Specialization in asthma
No 1.0 1.0
Yes 2.3 (1.8-3.1) <0.001 2.1 (1.5-3.0) <0.001
Participation in education supporting
SC counselling
No 1.0 1.0
Yes 3.3 (2.4-4.7) <0.001 2.1 (1.5-3.1) <0.001
Perceives health care’s support needed in SC
Never 1.0 1.0
Seldom 2.6 (1.2-5.7) 0.010 2.0 (0.9-5.0) 0.104
Always or almost always 4.3 (1.9-9.4) 0.021 2.7 (1.2-6.6) 0.022
Perceives own personal skills and knowledge
adequate to support SC
No 1.0 1.0
No opinion 2.8 (1.5-5.2) 0.001 3.5 (1.6-7.4) 0.001
Yes 5.0 (3.1-7.9) <0.001 3.8 (2.2-6.5) <0.001
Perceives customers value of NRT counseling
Disagree 1.0 1.0
No opinion 2.2 (1.0-4.7) 0.016 3.3(1.3-8.7) 0.016
Agree 2.4 (1.2-4.5) 0.044 2.3 (1.0-5.4) 0.044
Smoked at least 100 cigarettes up to date
No 1.0 1.0
Yes 1.5 (1.1-1.9) 0.003 1.7 (1.2-2.3) 0.001
SC services available in the respondent’s workplace
SC counseling supporting pocket card in use
Never 1.0 1.0
Sometimes 2.0 (1.5-2.6) <0.001 1.7 (1.3-2.4) 0.002
Always 3.9 (2.8-5.5) <0.001 3.0 (2.0-4.4) <0.001
In-house guideline in NRT dispensing in use
No 1.0 1.0
Yes, oral 2.3 (1.7-3.1) <0.001 1.5 (1.0-2.1) 0.030
Yes, written 2.4 (1.8-3.3) <0.001 1.8 (1.3-2.6) 0.001
Participation in local multidisciplinary
SC actions
No 1.0 1.0
Yes 3.5 (2.5-4.8) <0.001 2.4 (1.6-3.5) <0.001
* Adjusted for all the variables shown in the table. Logistic regression analysis: R2 = 0.264 (Nagelkerke) and Goodness-of-fit test (Hosmer-Lemeshow): 1,312;
p = 0.995. CI = Confidence Interval
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(Table 2). In the Likert-type statements measuring
respondents’ perceptions of the importance of SC and
healthcare’s role in it (Table 2), the options “Always”
and “Almost always” were reclassified as “Always";
options “Strongly agree” and “Agree” to “Agree"; and
correspondingly “Disagree” and “Strongly disagree” to
“Disagree”. The pharmacy’s location by province was re-
classified to four regions: Southern, Eastern, Western
and Northern (combination of options Oulu and Lap-
land) Finland (Tables 1 and 2).
Statistical analysis
The statistical analysis was based on bivariate and multi-
variate analysis. The statistical significance in the bivari-
ate analysis was tested by Chi Square test (p-value of
<0.05 was considered statistically significant). In the
multivariate analysis, logistic regression was applied to
control for a concomitant effect of the background vari-
ables selected for the analysis on the basis of the bivari-
ate analysis. The main outcome variable measuring
respondents’ familiarity with the Guideline was dichoto-
mized (1 = Respondent familiar with the Guideline; 0 =
Unfamiliar). The Spearman’s correlations between the
background variables were calculated to avoid possible
multicolinearity. Of the two variable pairs with a corre-
lation co-efficient of 0.6 or more, (respondent’s age and
graduation year; and “Smoking pass in use” and “Pocket
card to support SC counseling in use”), respondent’s age
and use of a SC pocket card were included in the
regression analysis. A backward step-wise logistic
Table 4 Implementation of the SC Guideline-based actions among the pharmacists familiar and unfamiliar with the
Guideline.
SC Guideline based actions and services Familiar with the SC
Guideline (n = 512)
Unfamiliar with the SC
Guideline (n = 625)
p-value*
% %
Workplace involvement in local multidisciplinary SC actions
Participation in a joint training 15 5 <0.001
Considered joint practices 12 5 <0.001
Have joint practices 5 2 <0.001
Recommends SC Guideline-based pharmacological treatment
Nicotine gum 94 96 0.450
Nicotine patch 86 80 0.010
Nicotine inhaler 22 20 0.345
Bupropion (Zyban®) 15 10 0.080
Recommends SC Guideline-based non-pharmacological tools
Own quitting decision 68 62 0.020
Written SC support material 56 41 <0.001
Participation in “Quit and Win” competition 26 23 0.242
Support of family and/or friends 17 14 0.120
Telephone-based SC support 12 8 0.090
Pharmacy’s individually tailored SC service 10 6 0.006
Group therapy 9 5 0.027
Internet-based SC support 7 4 0.080
Advise to see a public health nurse 4 3 0.104
Follows at “least often” ** the 5A’s Intervention with smoking customers.
Advised to quit during the month prior the survey 12 3 <0.001
Told about how smoking effects medication during past month 10 2 <0.001
Asked about smoking during past week 9 2 <0.001
Assessed quitting date during past month 2 1 <0.001
Discusses always*** about smoking with customers who
Self-refer to their smoking 94 91 0.101
are pregnant 45 32 <0.001
buy SC medicines 35 17 <0.001
suffer from a smoking-related disease 18 7 <0.001
* Between the groups familiar and unfamiliar with the SC Guideline
** Reclassified from the options: “always”, “often”, “at least with every second customer”, “sometimes, never”. “Often” was considered as option “often or more
frequently”
*** “Always” from the original answering options: “always”, “ sometimes”, “never”
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regression analysis was conducted. The final model did
not include interaction terms. The associations between
the outcome and background variables were described
by Odds Ratios calculated from the B-estimates, and
p-values (Table 3). All the statistical analyses were con-
ducted by the SPSS analytical software, version 15 (SPSS
Inc., Chicago, IL).
Results
Familiarity with the SC Guideline
Almost half (47%) of the responding pharmacists (n =
1190) were familiar with the SC Guideline (Table 2). In
bivariate analysis, the following variables related to indi-
vidual pharmacists’ characteristics positively influenced
the familiarity with the SC Guideline: specialization in
asthma; ever smoked 100 or more cigarettes; participa-
tion in continuing SC education; being a pharmacy
owner; and being older (Table 2). Also the following
variables reflecting respondents’ SC perceptions posi-
tively influenced the familiarity with the SC Guideline:
healthcare’s support needed in SC; own personal skills
and knowledge adequate to support SC; perception that
customers value NRT counseling; and perception that
cigarette smoke is extremely detrimental to health
(Table 2). Of the background variables related to
respondent’s working pharmacy, its location by province
and dispensing counter design were associated with the
Guideline familiarity (Table 2). All the variables measur-
ing availability of SC services at the respondent’s work-
ing pharmacy, e.g., use of SC pocket card, participation
in local multidisciplinary SC actions, individually tai-
lored SC service, and in-house guideline on NRT dis-
pensing, were associated with the SC Guideline
familiarity (Table 2).
In the multivariate analysis, nine out of the 21 vari-
ables were found to have a statistically significant asso-
ciation with the SC Guideline familiarity. The highest
ORs were found in the variables related to own percep-
tion of the personal skills and knowledge in SC (OR
3.8); perception of customers value NRT counseling
(OR 3.3); and regular use of the pocket card in SC
counseling (OR 3.0; all variables, p ≤ 0.001) (Table 3).
Guideline Familiarity and implementation of the SC
Guideline-based actions
Implementation of the Guideline-based SC actions and
services were more common among the respondents
familiar with the Guideline (Table 4). The familiarity
with the Guideline was strongly associated with respon-
dents’ working pharmacy’s participation in local multi-
disciplinary SC actions, the frequency of applying the
5A’s Intervention with smoking customers and the dis-
cussion about SC with customers who have higher risk
factors or buy SC medicines. These actions were not so
commonly taken compared to recommending NRT gum
or patch, which were reported by almost all respondents
despite their Guideline familiarity. Similarly, nearly all
the respondents reported, that they always discuss about
SC with customers who spontaneously refer to his/her
smoking. The same applies to supporting smoker’s own
quitting decision which was done by more than 60% of
the respondents.
Discussion
This National study showed that approximately half
(47%) of the responding pharmacists were familiar with
the Finnish SC Guideline [7]. The Guideline familiarity
was positively associated with the pharmacist’s positive
perception towards SC and SC actions taken in their
workplace. On the other hand, no variables related to
the characteristics of the workplace, such as pharmacy’s
size or ownership, geographical location or dispensing
counter design influenced SC Guideline familiarity.
Healthcare professionals’ unfamiliarity with the exist-
ing guidelines or their contents is considered a major
barrier for successful guideline implementation [15,38].
According to a survey conducted among community
pharmacists in Iowa in 2002, only 10% of the respon-
dents were familiar with the US SC Guideline (Addi-
tional File 1, Table S1) [23]. In our study, approximately
half of the pharmacists were familiar with the Finnish
SC Guideline, i.e., they reported to know its main prin-
ciples or have even better knowledge of it. This is very
much in line with the survey of Ward et al. [14] report-
ing about half of the responding physicians in Australia
being familiar with a National SC guideline. Interest-
ingly, in that study [14], even more physicians self-
reported that they followed the SC guideline’s major
recommendations than indicated being familiar with it.
We had an opposite result in this respect with less
respondents reporting implementation than familiarity
with the Guideline. However, we found that the Guide-
line familiarity was associated with its implementation.
These results illustrate the challenging nature of guide-
line implementation and the difficulty to assess the
actual implementation, which has been widely studied
[14-16,38,41]. The findings may also indicate differences
between health professionals in bringing the SC guide-
lines into daily practice. It would be interesting to com-
pare the SC guidelines implementation among different
healthcare professionals with a sound methodology that
allows reliable comparison.
In our study, the SC Guideline familiarity was more
common among pharmacists who perceived that health-
care professionals are always needed in SC and were
satisfied with their own personal SC skills and knowl-
edge. Also the perception that customers value their
NRT counseling positively influenced the Guideline
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familiarity. This is parallel to earlier findings of health-
care professionals’ high personal motivation and positive
attitude enhancing guideline implementation
[6,16,38,39,42]. Correspondingly, studies conducted
among community pharmacists found the association
between good professional self-esteem and current SC
practice (Additional File 1, Table S1) [8,23-26]. Health-
care professional’s knowledge and SC perceptions can
be enhanced by effective SC education and training,
which should also focus on improving their-self esteem
and understanding of their crucial role in SC [43,44].
According to a German survey among physicians, the
association between SC training received and level of SC
activeness might be linear [10].
Motivation to implement the SC Guideline may also
be influenced by the economic value of SC services and
the sale of SC medicines, as well as their reimbursement
status [10,27]. In Finland, NRT products were released
for general sale in 2006 and this has remarkably
decreased the NRT sales in community pharmacies [45].
Despite this, community pharmacy owners’ and staff
pharmacists’ commitment to SC was strong one year
after the deregulation. It would be interesting to make a
follow-up study to assess the development of the moti-
vation in the long term and to follow the Guideline
implementation rate.
Our findings suggest that the SC Guideline familiarity
does not influence the recommendation of NRT pro-
ducts to smoking customers, which was clearly the most
common SC action taken place among all the respon-
dents. However, the familiarity was associated with the
use of more sophisticated SC methods, such as recom-
mending non-pharmacological methods, use of 5A’s
Intervention and participation in local multidisciplinary
SC actions. Similarly, a survey among Australian physi-
cians found a high rate of NRT recommendation,
whereas behavioral or quitting advice or quit date set-
ting were far rare [6]. Though the SC Guideline under-
lines the importance of local multidisciplinary
collaboration, it proved to be a rare in our study. This
finding is in accordance with earlier findings in Finland
[46]. These findings suggest that there is a lot of work
needed in order to achieve the key aim of the SC Guide-
line - to promote multidisciplinary care. It would be
interesting to find out whether the situation is the same
in other countries.
Our responses indicate that customers’ degree of
initiative significantly influences community pharma-
cists’ SC counseling activity. This is in line with previous
studies conducted among pharmacists (Additional File 1,
Table S1) [23,24]. Community pharmacists’ familiarity
with the SC Guideline particularly influences their coun-
seling activity with customers being extremely vulner-
able for tobacco use (e.g. pregnant women and those
who suffer from smoking-related diseases). These find-
ings underline the importance of making the SC Guide-
line widely known among pharmacists and other
healthcare professionals if they are required to provide
sophisticated SC services in their community.
According to several previous studies, the working
place has an important role in enhancing guideline
familiarity and implementation [13,15,38,39]. In our
study, SC services available in the workplace increased
the familiarity with the Guideline, whereas characteris-
tics of the workplace, such as pharmacy’s size and geo-
graphical location did not influence on it. These
findings suggest that all Finns may have equal access to
SC services provided by community pharmacies regard-
less of where they life. This is important from a public
health viewpoint, and opposite to the recent findings
from the USA; the study conducted in the pharmacies
of New York City area found better availability and
lower prices of NRT products in the pharmacies of the
wealthiest living areas [47].
Our nationwide study based on a representative sam-
ple (n = 1190) (Table 1) of Finnish community pharma-
cists had a relatively high response rate (54%) compared
to other surveys conducted among community pharma-
cists [8,20]. There were no statistically significant differ-
ences between the respondent and target population
with the following exception (Table 1). The pharmacists
specialized in the treatment of asthma, diabetes or cardi-
ovascular diseases, under the public health program of
the AFP, responded more often than other pharmacists
(see Methods, Context and study design, Table 1), this
can be understood by their higher interest in SC and
stronger professional role in SC. However, their propor-
tion of the overall study respondents may overestimate
the actual Guideline familiarity.
Respondents’ familiarity with the SC Guideline was
chosen to be our main outcome measure. We consid-
ered it to be more reliable for the respondents to assess
their own familiarity with the Guideline than the actual
level of implementation, which can be biased by limited
ability to recall or by self-perceptions. In further studies,
it might be useful to conduct an analysis using Guide-
line-based actions as the outcome variables and include
Guideline familiarity alongside with other background
variables to estimate the relative impact of Guideline
familiarity on practice. However, the level of actual
implementation can be more reliably assessed by popu-
lation based intervention studies or pseudo patron
studies.
Our survey was conducted in 2006 - 2007, i.e., about
four years ago. Since then, tobacco control policy has
changed in Finland supporting more smoke-free public
areas, such as restaurants, workplaces and even munici-
palities. Also a new prescription medicine has been
Kurko et al. BMC Public Health 2010, 10:444
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launched for SC in 2006. Despite these remarkable
changes no follow-ups on effectiveness of SC or health
care professionals practices has been recently conducted.
It would be interesting to repeat this study to see
whether any changes have taken place in this respect.
Conclusions
Nearly half of the Finnish community pharmacists were
familiar with the National Current Care Guideline in SC
at the time of our survey. Pharmacists’ Guideline famil-
iarity can be enhanced by supporting their positive per-
ceptions towards cessation, its importance and by
offering continuing education. Further, the workplace
(pharmacy) has an important role by providing Guide-
line-based SC services, and thus, support pharmacists’
activeness in SC. Pharmacists’ good knowledge and self-
esteem towards SC alongside with SC supportive in-
house practices at pharmacy are in crucial role while
supporting the implementation. Among Guideline famil-
iar pharmacists, the Guideline-based SC actions and ser-
vices are better implemented than among respondents
unfamiliar with the Guideline.
Additional material
Additional file 1: Table S1: Examples of studies showing community
pharmacists’ participation in SC. This file contains an additional table,
providing information of the studies of community pharmacists
participation in SC.
Additional file 2: Table S2: The Community pharmacists’ duties in
the treatment chain of SC according to the National SC Guideline
[7]. This file contains an additional table proving information about the
SC tasks the Guideline requires from community pharmacists.
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